Missouri Attorney General Catherine Hanaway filed a federal lawsuit Thursday challenging the Food and Drug Administration’s approval of a new generic version of the abortion drug mifepristone.
Hanaway is arguing that the decision endangers women by allowing unchecked mail-order distribution without basic medical safeguards.
The suit, joined by Kansas and Idaho, seeks to block the September 30 approval of the generic product from Evita Solutions and restore pre-2016 safety standards for the drug, including requirements for in-person medical evaluations to detect life-threatening conditions like ectopic pregnancies.
Hanaway, a Republican, said the lawsuit supports Missouri’s ongoing multi-state challenge against the FDA’s rollback of safety protections mandated by Congress for mifepristone, which is used in the abortions. The abortion pill has killed multiple women and injured countless thousands.